




Searching News Database: neuroendocrine cancer
HSMN NewsFeed - 3 Jun 2008
Lexicon's Drug Candidate for Carcinoid Syndrome Receives Fast Track Status From the FDA
Lexicon's Drug Candidate for Carcinoid Syndrome Receives Fast Track Status From the FDA
HSMN NewsFeed - 15 Oct 2007
Covidien and BioSynthema Sign Exclusive Agreements for Cancer Therapy Technology
Covidien and BioSynthema Sign Exclusive Agreements for Cancer Therapy Technology
HSMN NewsFeed - 3 Jun 2007
Xanthus Announces Phase 1 Results for P2045 - a Targeted Agent for Non-Small Cell Lung Cancer
Xanthus Announces Phase 1 Results for P2045 - a Targeted Agent for Non-Small Cell Lung Cancer
HSMN NewsFeed - 30 May 2007
Delcath Systems Receives National Cancer Institute Approval to Expand Phase III Trial to Multiple Centers
Delcath Systems Receives National Cancer Institute Approval to Expand Phase III Trial to Multiple Centers
HSMN NewsFeed - 7 Nov 2006
Callisto Pharmaceuticals Initiates Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer
Callisto Pharmaceuticals Initiates Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer
HSMN NewsFeed - 6 Sep 2006
Xanthus Pharmaceuticals Licenses Novel Cancer Targeting Agents From Schering AG, Berlin
Xanthus Pharmaceuticals Licenses Novel Cancer Targeting Agents From Schering AG, Berlin
HSMN NewsFeed - 17 May 2006
Neotropix Receives FDA Approval to Begin Clinical Trials With First Investigational Cancer Drug
Neotropix Receives FDA Approval to Begin Clinical Trials With First Investigational Cancer Drug
Additional items found! 3

Members Archive contains
3 additional stories matching:
neuroendocrine cancer
(Password required)
neuroendocrine cancer
(Password required)